Cancer

January 17, 2008

Pietenpol Chosen to Lead Vanderbilt-Ingram Cancer Center

Jennifer Pietenpol, Ph.D., Ingram Professor of Cancer Research and professor of Biochemistry, has been named director of Vanderbilt-Ingram Cancer Center.
October 25, 2007

New review clears silicone gel breast implants of serious health risks; Vanderbilt-Ingram Cancer Center researchers find no cancer link

Women who receive silicone gel-filled breast implants do not have a higher risk of breast cancer or other cancers and do not experience lower survival rates after breast cancer diagnosis, according to a new report published in the November issue of Annals of Plastic Surgery. This is the first exhaustive review in almost a decade of the health effects of cosmetic breast implants.

By VUMC News and Communications
August 29, 2007

Prostate cancer patients may be eligible for less invasive therapy; Vanderbilt-Ingram Cancer Center first in state to test new ultrasound procedure

Men with prostate cancer now may have access to a new, minimally invasive surgical procedure. Urologic surgeons at Vanderbilt-Ingram Cancer Center will be the first in Tennessee to test the new Ablatherm procedure, which uses high-intensity focused ultrasound (HIFU) to destroy cancerous prostate tissue without any incision.

By VUMC News and Communications
February 23, 2007

Vanderbilt-Ingram clinic space expanding to meet needs of patients

When the dust settles on a new renovation project involving Vanderbilt-Ingram Cancer Center‘s Henry-Joyce Cancer Clinic, waiting room space and exam rooms will nearly double to help meet the needs of an ever increasing number of cancer patients in Middle Tennessee and beyond.
February 22, 2007

Vanderbilt-Ingram Cancer Center Receives Highest Level of Approval

Vanderbilt-Ingram Cancer Center has received a three-year accreditation with commendation, the highest level of approval, from the Commission on Cancer of the American College of Surgeons (ACoS).

By VUMC News and Communications
January 29, 2007

Vanderbilt-Ingram Cancer Center receives $6.5 million grant to study tumor environment

Like a seed needs soil to grow and flourish, a tumor relies on its environment to grow and spread in the body — something the Vanderbilt-Ingram Cancer Center will be exploring more closely with the help of a new $6.5 million grant from the National Cancer Institute (NCI).

By VUMC News and Communications
January 29, 2007

Pietenpol Named Interim Director of Vanderbilt-Ingram Cancer Center

Jennifer A. Pietenpol, Ph.D., has been selected to lead the Vanderbilt-Ingram Cancer Center as interim director.
January 10, 2007

Vanderbilt-Ingram Cancer Center Director To Return To Home State For Post At MD Anderson

Raymond DuBois Jr., M.D., Ph.D., will leave his position as director of the Vanderbilt-Ingram Cancer Center later this year to return to his native Texas as provost and executive vice president of academic affairs at M.D. Anderson Cancer Center in Houston.
November 28, 2006

MEHARRY/VANDERBILT-INGRAM CANCER PARTNERSHIP AWARDED $14 MILLION GRANT FOR CANCER STUDY

The Meharry/Vanderbilt-Ingram Cancer Partnership has been awarded $14 million by the National Cancer Institute for research that seeks to reduce cancer mortality among African Americans and other minorities.
November 28, 2006

Vanderbilt-Ingram Cancer Center, AstraZeneca Form Master Agreement to Streamline Research Collaborations

The Vanderbilt-Ingram Cancer Center and AstraZeneca have developed a master scientific agreement to streamline and integrate collaborations in basic, translational and clinical cancer research, officials with the company and cancer center announced today.
June 8, 2006

First Adult Cancer Patient in Nashville to Receive Stem Cell Transplant from Umbilical Cord Blood at Vanderbilt-Ingram Cancer Center

When 24-year-old Charles Dougherty checks into Vanderbilt-Ingram Cancer Center tomorrow, he'll be preparing for a treatment that has never been performed before in an adult patient in Nashville, and will be only the second case in Tennessee history.
By VUMC News and Communications
April 17, 2006

Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant

Initial Results of the Study of Tamoxifen and Raloxifene or STAR, released today revealed the osteoporosis drug raloxifene has been proved to be as effective as tamoxifen in preventing invasive breast cancer.
By VUMC News and Communications
March 20, 2006

Vanderbilt-Ingram Cancer Center Research Earns Funding from Lance Armstrong Foundation to Study Effects of Exercise on Curbing Memory Problems Associated with Chemotherapy

Researchers at the Vanderbilt-Ingram Cancer Center are studying whether exercise can help curb memory and cognitive problems experienced by many cancer survivors following chemotherapy.
By VUMC News and Communications
1 … 60 61 62 63 64 … 69